Akero Therapeutics Announces Pricing of Initial Public Offering

SAN FRANCISCO, June 19, 2019 /PRNewswire/ -- Akero Therapeutics, Inc. (NASDAQ: AKRO), a clinical-stage biotechnology company developing transformational treatments for people with non-alcoholic steatohepatitis (NASH) and other serious metabolic disorders, today announced the pricing of its initial public offering of 5,750,000 shares of common stock at a public offering price of $16.00 per share. All of the shares are being offered by Akero. The shares are expected to begin trading on the Nasdaq Global Select Market on June 20, 2019 under the ticker symbol "AKRO." The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Akero, are expected to be approximately $92.0 million. The offering is expected to close on June 24, 2019, subject to the satisfaction of customary closing conditions. In addition, Akero has granted the underwriters a 30-day option to purchase up to an additional 862,500 shares of common stock at the initial public offering price.

Full ArticleWed Jun 19, 2019 8:20pm ESTAkero Therapeutics, Inc.

Property prices in Hong Kong force people to explore various alternatives to achieve their dream of owning property

squarefoot.com.hk releases '2019 H1 Hong Kong Real Estate Market Outlook' findings

Full ArticleWed Jun 19, 2019 8:19pm ESTREA Group


Stock Market | Trending Ideas & Opinions Stream

Cryoport Announces Pricing of Public Offering of Common Stock

IRVINE, Calif., June 19, 2019 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) (Nasdaq: CYRXW) ("Cryoport" or the "Company") today announced the pricing of its underwritten public offering of an aggregate of 3,750,000 newly issued shares of common stock at a price of $17.00 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 562,500 shares of common stock. The net proceeds to the Company from the offering of the shares are expected to be approximately $59.8 million after deducting underwriting discounts and commissions and estimated offering expenses, and assuming no exercise of the underwriters' option to purchase additional shares. Subject to customary conditions, the offering is expected to close on June 24, 2019.

Full ArticleWed Jun 19, 2019 8:02pm ESTCryoport, Inc.

NGEx Securityholders Approve Spin-Out of Los Helados Project and Exploration Properties

VANCOUVER, June 19, 2019 /CNW/ - NGEx Resources Inc. (TSX: NGQ) (Nasdaq Stockholm: NGQ) ("NGEx" or the "Company") is pleased to announce that at the Annual Meeting (the "Annual Meeting") of shareholders and Special Meeting (the "Special Meeting" and together with the Annual Meeting, the "Meeting") of shareholders and optionholders of the Company (together, the "NGEx Securityholders") held on June 19, 2019, the "NGEx Securityholders have approved the previously announced proposed spin-out of the Company's Los Helados Property (the "Los Helados Project") and certain other exploration properties into a wholly owned subsidiary of NGEx, NGEx Minerals Ltd. ("Spinco"). At the Special Meeting, a special resolution approving the transaction was approved by 99.90% of the votes cast at the meeting in person or by proxy by NGEx Securityholders, voting together as a single class. In addition, shareholders of the Company ("NGEx Shareholders") have voted 99.96% (in person or by proxy) in favour to approve the stock option plan of Spinco.

Full ArticleWed Jun 19, 2019 6:00pm ESTNGEx Resources Inc.

Prometic Announces Voting Results of its 2019 AGM

LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, June 19, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or the "Corporation") announced the voting results from its 2019 Annual General and Special Meeting of Shareholders ("AGM") held in Montreal, Quebec. A total of 16,792,591,957 common shares were voted, representing 81.04% of the votes attached to the issued and outstanding common shares of Prometic.

Full ArticleWed Jun 19, 2019 5:58pm ESTProMetic Life Sciences Inc.

Canopy Rivers to Report Fourth Quarter and Fiscal Year 2019 Financial Results

TORONTO, June 19, 2019 /CNW/ - Canopy Rivers Inc. (the "Company") (TSXV: RIV) (OTC: CNPOF) will report its financial results for the fourth quarter and fiscal year ended March 31, 2019 before markets open on Tuesday, July 16, 2019. The Company's audited consolidated financial statements and Management's Discussion and Analysis for the three and twelve months ended March 31, 2019 will be available on the Company's profile on SEDAR at www.sedar.com and in the Investors section of the Company's website at www.canopyrivers.com.

Full ArticleWed Jun 19, 2019 5:56pm ESTCanopy Rivers Inc.

Canopy Rivers to Report Fourth Quarter and Fiscal Year 2019 Financial Results

TORONTO, June 19, 2019 /PRNewswire/ - Canopy Rivers Inc. (the "Company") (TSXV: RIV) (OTC: CNPOF) will report its financial results for the fourth quarter and fiscal year ended March 31, 2019 before markets open on Tuesday, July 16, 2019. The Company's audited consolidated financial statements and Management's Discussion and Analysis for the three and twelve months ended March 31, 2019 will be available on the Company's profile on SEDAR at www.sedar.com and in the Investors section of the Company's website at www.canopyrivers.com.

Full ArticleWed Jun 19, 2019 5:56pm ESTCanopy Rivers Inc.

Avon Announces Cash Tender Offer for 2020 Notes

LONDON, June 19, 2019 /PRNewswire/ -- Avon Products, Inc. (NYSE: AVP) ("we," "us," "our" or "Avon") announced today that it has commenced a cash tender offer (the "Tender Offer"), subject to certain terms and conditions, to purchase any and all of its 4.600% Notes due 2020 (the "Notes").

Full ArticleWed Jun 19, 2019 5:46pm ESTAvon Products, Inc.

Equitable Bank Renews $400 Million Secured Backstop Facility

TORONTO, June 19, 2019 /CNW/ - Equitable Group Inc. (TSX:EQB and EQB.PR.C) ("Equitable" or "Company") today announced it has closed a $400 million secured backstop liquidity facility with a syndicate of Canadian bank lenders led by The Toronto-Dominion Bank and including Bank of Montreal, CIBC, National Bank, and Scotiabank.

Full ArticleWed Jun 19, 2019 5:46pm ESTEquitable Group Inc.

Avon Announces Senior Secured Notes Offering

LONDON, June 19, 2019 /PRNewswire/ -- Avon Products, Inc. (NYSE: AVP) (the "Company" or "Avon") announced today that Avon International Capital p.l.c., Avon's wholly-owned subsidiary (the "Issuer"), intends to offer $350,000,000 in aggregate principal amount of its senior secured notes due 2022 (the "notes"). The notes will be guaranteed by the Company and each of the Company's current and future wholly-owned subsidiaries that is a guarantor under the Issuer's Revolving Credit Agreement, dated as of February 12, 2019 (as amended or supplemented, the "First Lien Revolving Credit Facility"). The notes and guarantees will be secured equally and ratably by the assets of the Issuer and the guarantors that secure the First Lien Revolving Credit Facility and the outstanding 7.875% Senior Secured Notes due 2022 issued by the Company's wholly owned subsidiary, Avon International Operations, Inc. (the "Existing 2022 Notes"). The terms of the notes will be substantially similar to the terms of the Existing 2022 Notes.

Full ArticleWed Jun 19, 2019 5:45pm ESTAvon Products, Inc.